ORIGINAL RESEARCH
Published on 18 Mar 2024
Assessment of the implementation of accelerated drug marketing registration procedures for antineoplastic and immunomodulating agents in China: based on 2016–2022 review data
doi 10.3389/fphar.2024.1345672
- 1,114 views
- 2 citations